Metraipolis › archive › dc_508d53fe32b3

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes — Europe PMC PMID:41663281

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41663281
DOI
10.1136/bmjdrc-2025-005672
License (as archived)
solo-consultazione
Archived
2026-11-06T00:46:10.902Z
SHA-256 of the archived text
81147fda2672285fff2ffe42f79ba7f5eed63391d2237faa017916f29283e37a
Stable URL of this page
https://metraipolis.com/documento/dc_508d53fe32b3

How to cite

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes — Europe PMC PMID:41663281 — Europe PMC (en), https://europepmc.org/article/MED/41663281 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_508d53fe32b3 (Metraipolis archive dc_508d53fe32b3, sha256 81147fda2672285fff2ffe42f79ba7f5eed63391d2237faa017916f29283e37a)
BibTeX
@misc{dc508d53fe32b3,
  title = {Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes — Europe PMC PMID:41663281},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41663281},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_508d53fe32b3; sha256 81147fda2672285fff2ffe42f79ba7f5eed63391d2237faa017916f29283e37a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41663281. Agents can read the archived copy with the MCP tool read_document.